Luye Pharma Group Ltd. (HKG:2186)
Hong Kong
· Delayed Price · Currency is HKD 2.320
-0.020 (-0.85%)
Mar 3, 2025, 4:08 PM HKT
Luye Pharma Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 28, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Market Capitalization | 8,727 | 14,031 | 12,992 | 12,607 | 11,729 | 19,091 | Upgrade
|
| Market Cap Growth | -18.43% | 8.00% | 3.05% | 7.49% | -38.56% | 7.12% | Upgrade
|
| Enterprise Value | 13,066 | 17,078 | 18,013 | 16,610 | 16,596 | 21,869 | Upgrade
|
| Last Close Price | 2.32 | 3.73 | 3.66 | 3.56 | 3.61 | 5.77 | Upgrade
|
| PE Ratio | 10.54 | 23.91 | 19.00 | - | 13.98 | 12.22 | Upgrade
|
| Forward PE | 9.92 | 17.57 | 17.45 | 8.01 | 6.62 | 9.73 | Upgrade
|
| PS Ratio | 1.29 | 2.07 | 1.92 | 1.98 | 1.78 | 2.68 | Upgrade
|
| PB Ratio | 0.62 | 0.94 | 1.04 | 1.13 | 1.22 | 1.91 | Upgrade
|
| P/TBV Ratio | 1.72 | 1.91 | 2.43 | 3.00 | 3.22 | 4.53 | Upgrade
|
| P/FCF Ratio | - | 13.23 | 11.51 | - | 28.99 | 40.32 | Upgrade
|
| P/OCF Ratio | 18.48 | 7.98 | 6.95 | 56.32 | 9.56 | 12.00 | Upgrade
|
| PEG Ratio | 0.53 | 0.84 | 0.84 | 0.84 | 0.84 | 0.85 | Upgrade
|
| EV/Sales Ratio | 1.93 | 2.52 | 2.66 | 2.60 | 2.52 | 3.07 | Upgrade
|
| EV/EBITDA Ratio | 6.09 | 9.98 | 11.18 | 14.92 | 9.52 | 9.67 | Upgrade
|
| EV/EBIT Ratio | 9.46 | 17.47 | 20.19 | 37.24 | 14.14 | 12.26 | Upgrade
|
| EV/FCF Ratio | -100.26 | 16.10 | 15.96 | - | 41.02 | 46.18 | Upgrade
|
| Debt / Equity Ratio | 0.67 | 0.62 | 0.82 | 1.04 | 1.23 | 0.96 | Upgrade
|
| Debt / EBITDA Ratio | 4.74 | 5.33 | 6.27 | 10.09 | 6.68 | 4.18 | Upgrade
|
| Debt / FCF Ratio | - | 8.75 | 9.12 | - | 29.30 | 20.20 | Upgrade
|
| Asset Turnover | 0.24 | 0.25 | 0.26 | 0.24 | 0.28 | 0.34 | Upgrade
|
| Inventory Turnover | 2.44 | 2.42 | 2.42 | 2.65 | 2.52 | 2.46 | Upgrade
|
| Quick Ratio | 1.03 | 1.08 | 0.83 | 1.08 | 1.00 | 1.02 | Upgrade
|
| Current Ratio | 1.28 | 1.32 | 1.14 | 1.42 | 1.38 | 1.67 | Upgrade
|
| Return on Equity (ROE) | 6.33% | 4.39% | 5.79% | -1.68% | 8.26% | 16.07% | Upgrade
|
| Return on Assets (ROA) | 3.00% | 2.23% | 2.11% | 1.05% | 3.09% | 5.39% | Upgrade
|
| Return on Capital (ROIC) | 3.52% | 2.63% | 2.55% | 1.24% | 3.48% | 6.32% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.37% | 5.11% | 5.35% | 2.38% | 7.38% | 11.64% | Upgrade
|
| Earnings Yield | 9.49% | 4.18% | 5.26% | -1.31% | 7.15% | 8.18% | Upgrade
|
| FCF Yield | -1.49% | 7.56% | 8.69% | -3.64% | 3.45% | 2.48% | Upgrade
|
| Dividend Yield | 0.00% | - | - | - | - | 2.19% | Upgrade
|
| Payout Ratio | 0.00% | - | - | - | 24.84% | 26.99% | Upgrade
|
| Buyback Yield / Dilution | -4.81% | -7.11% | -1.03% | -7.87% | 0.85% | 0.01% | Upgrade
|
| Total Shareholder Return | -4.81% | -7.11% | -1.03% | -7.87% | 0.85% | 2.20% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.